Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis.
O'Neil LJ, Hu P, Liu Q, Islam MM, Spicer V, Rech J, Hueber A, Anaparti V, Smolik I, El-Gabalawy HS, Schett G, Wilkins JA.
O'Neil LJ, et al. Among authors: hu p.
Front Immunol. 2021 Nov 18;12:729681. doi: 10.3389/fimmu.2021.729681. eCollection 2021.
Front Immunol. 2021.
PMID: 34867950
Free PMC article.
Clinical Trial.